Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Stroke ; 9(1): 126-32, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24207098

RESUMO

BACKGROUND AND HYPOTHESIS: Thrombolysis with tissue plasminogen activator is proven to reduce disability when given within 4·5 h of ischemic stroke onset. However, tissue plasminogen activator only succeeds in recanalizing large vessel arterial occlusion in a minority of patients. We hypothesized that anterior circulation ischemic stroke patients, selected with 'dual target' vessel occlusion and evidence of salvageable brain using computed tomography or magnetic resonance imaging 'mismatch' within 4·5 h of onset, would have improved reperfusion and early neurological improvement when treated with intra-arterial clot retrieval after intravenous tissue plasminogen activator compared with intravenous tissue plasminogen activator alone. STUDY DESIGN: EXTEND-IA is an investigator-initiated, phase II, multicenter prospective, randomized, open-label, blinded-endpoint study. Ischemic stroke patients receiving standard 0·9 mg/kg intravenous tissue plasminogen activator within 4·5 h of stroke onset who have good prestroke functional status (modified Rankin Scale <2, no upper age limit) will undergo multimodal computed tomography or magnetic resonance imaging. Patients who also meet dual target imaging criteria: vessel occlusion (internal carotid or middle cerebral artery) and mismatch (perfusion lesion : ischemic core mismatch ratio >1·2, absolute mismatch >10 ml, ischemic core volume <70 ml) will be randomized to either clot retrieval with the Solitaire FR device after full dose intravenous tissue plasminogen activator, or tissue plasminogen activator alone. STUDY OUTCOMES: The coprimary outcome measure will be reperfusion at 24 h and favorable clinical response (reduction in National Institutes of Health Stroke Scale by ≥8 points or reaching 0-1) at day 3. Secondary outcomes include modified Rankin Scale at day 90, death, and symptomatic intracranial hemorrhage.


Assuntos
Projetos de Pesquisa , Acidente Vascular Cerebral/terapia , Trombectomia/métodos , Terapia Trombolítica/métodos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Fibrinolíticos/uso terapêutico , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Imagem Multimodal , Ativador de Plasminogênio Tecidual/uso terapêutico , Tomografia Computadorizada por Raios X , Adulto Jovem
2.
J Neurosurg ; 103(1): 176-8, 2005 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16121989

RESUMO

In this report the authors describe a patient in whom a symptomatic carotid-cavernous fistula developed 8 months after percutaneous balloon compression of the trigeminal ganglion. The fistula involved a branch of the external carotid artery and was cured with microcatheter embolization.


Assuntos
Fístula Arteriovenosa/etiologia , Cateterismo/efeitos adversos , Seio Cavernoso/patologia , Artérias Meníngeas/patologia , Gânglio Trigeminal , Idoso , Fístula Arteriovenosa/diagnóstico por imagem , Fístula Arteriovenosa/patologia , Seio Cavernoso/diagnóstico por imagem , Feminino , Humanos , Artérias Meníngeas/diagnóstico por imagem , Radiografia , Neuralgia do Trigêmeo/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...